Pinnacle Wealth Planning Services’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.6K Hold
7,355
﹤0.01% 1452
2026
Q1
$27.4K Hold
7,355
﹤0.01% 1529
2025
Q4
$60.2K Buy
+7,355
New +$54.4K 0.01% 1076
2024
Q4
Sell
-14,697
Closed -$72.5K 490
2024
Q3
$72.5K Sell
14,697
-789
-5% -$4.12K 0.01% 514
2024
Q2
$79.4K Hold
15,486
0.01% 490
2024
Q1
$82.2K Sell
15,486
-2,254
-13% -$16.1K 0.01% 488
2023
Q4
$110K Sell
17,740
-1,131
-6% -$7.85K 0.02% 455
2023
Q3
$142K Hold
18,871
0.02% 384
2023
Q2
$182K Sell
18,871
-154
-0.8% -$940 0.03% 394
2023
Q1
$71.8K Buy
+19,025
New +$106K 0.01% 452

Other funds holding LFCR

Pinnacle Wealth Planning Services's LFCR Position: Q2 2026 in Review

Pinnacle Wealth Planning Services held its Lifecore Biomedical (LFCR) position steady in Q2 2026 at 7,355 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1452.

Pinnacle Wealth Planning Services first reported a position in LFCR in Q1 2023 and has held it in 10 quarters since. The position peaked at $182K in Q2 2023. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Pinnacle Wealth Planning Services held 7,355 shares of Lifecore Biomedical worth $38.6K as of Q2 2026.
  • Pinnacle Wealth Planning Services left its Lifecore Biomedical share count unchanged in Q2 2026.
  • Lifecore Biomedical made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1452 holding.
  • Pinnacle Wealth Planning Services first reported a position in Lifecore Biomedical in Q1 2023 and has held it in 10 quarters since.
  • Pinnacle Wealth Planning Services's Lifecore Biomedical position peaked at $182K in Q2 2023.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.